Evelyn Regar

Evelyn Regar

Auto-generated profile, based on publicly available information

Evelyn Regar

Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in JACC
Verified
Journal Article
Open access
AKAntonios Karanasos
Antonios Karanasos
CSCihan Simsek
Cihan Simsek
MGMuthukarrupan Gnanadesigan
Muthukarrupan Gnanadesigan
NDNienke S. van Ditzhuijzen
Nienke S. van Ditzhuijzen
RFRaphael Freire
Raphael Freire
EREvelyn Regar
Evelyn Regar
Although recent observations suggest a favorable initial healing process of the everolimus-eluting bioresorbable vascular scaffold (BVS), little is known regarding long-term healing response. This study assessed the in vivo vascular healing response using optical coherence tomography (OCT) 5 years after elective first-in-man BVS implantation. Of the 14 living patients enrolled in the Thoraxcenter Rotterdam cohort of the ABSORB A study, 8 patients underwent invasive follow-up, including OCT, 5 years after implantation. Advanced OCT image analysis included luminal morphometry, assessment of the adluminal signal-rich layer separating the lumen from other plaque components, visual and quantitative tissue characterization, and assessment of side-branch ostia "jailed" at baseline. In all patients, BVS struts were integrated in the vessel and were not discernible. Both minimum and mean luminal area increased from 2 to 5 years, whereas lumen eccentricity decreased over time. In most patients, plaques were covered by a signal-rich, low-attenuating layer. Minimum cap thickness over necrotic core was 155 ± 90 μm. One patient showed plaque progression and discontinuity of this layer. Side-branch ostia were preserved with tissue bridge thinning that had developed in the place of side-branch struts, creating a neo-carina. At long-term BVS follow-up, we observed a favorable tissue response, with late luminal enlargement, side-branch patency, and development of a signal-rich, low-attenuating tissue layer that covered thrombogenic plaque components. The small size of the study and the observation of a different tissue response in 1 patient warrant judicious interpretation of our results and confirmation in larger studies.

1 May 2015 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
PDF file
AKAntonios Karanasos
Antonios Karanasos
NMNicolas Van Mieghem
Nicolas Van Mieghem
NDNienke van Ditzhuijzen
Nienke van Ditzhuijzen
CFCordula Felix
Cordula Felix
JDJoost Daemen
Joost Daemen
EREvelyn Regar
Evelyn Regar
Background—: As bioresorbable vascular scaffolds (BVSs) are being increasingly used in complex real-world lesions and populations, BVS thrombosis cases have been reported. We present angiographic and optical coherence tomography (OCT) findings in a series of patients treated in our center for definite bioresorbable scaffold thrombosis. Methods and Results—: Up to June 2014, 14 patients presented with definite BVS thrombosis in our center. OCT was performed in 9 patients at the operator’s discretion. Angiographic and OCT findings were compared with a control group comprising 15 patients with definite metallic stent thrombosis. In the BVS group, time interval from index procedure to scaffold thrombosis ranged from 0 to 675 days. Incomplete lesion coverage by angiography was identified in 4 of 14 cases, malapposition by OCT in 5 of 9 cases, strut discontinuity in 2 of 9 cases, and underexpansion in 2 of 9 cases. Five patients had discontinued dual antiplatelet therapy, and in 3 of them discontinued dual antiplatelet therapy discontinuation had occurred the week preceding the event. There were no significant differences in angiographic or OCT findings between BVS and metallic stent thrombosis. Conclusions—: Suboptimal implantation with incomplete lesion coverage, underexpansion, and malapposition comprises the main pathomechanism for both early and late BVS thrombosis, similar to metallic stent thrombosis. Dual antiplatelet therapy discontinuation seems to also be a secondary contributor in several late events. Our observations suggest that several potential triggers for BVS thrombosis could be avoided.

10 July 2011 in Herz
Verified
Journal Article
Closed access
PDF file
ERE. Regar
E. Regar
JLJ. Ligthart
J. Ligthart
NBN. Bruining
N. Bruining
GSG. van Soest
G. van Soest

1 April 2007 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
JSJohannes A. Schaar
Johannes A. Schaar
FMFrits Mastik
Frits Mastik
EREvelyn Regar
Evelyn Regar
CUCornelis A. Den Uil
Cornelis A. Den Uil
FGFrank J. Gijsen
Frank J. Gijsen
ASA. F. W. van der Stehen
A. F. W. van der Stehen
Abstract: Rupture of vulnerable plaques is the main cause of acute coronary syndrome and myocardial infarction. Identification of vulnerable plaques is therefore essential to enable the development of treatment modalities to stabilize such plaques. Several diagnostic methods are currently tested to detect vulnerable plaques. Angiography has a low discriminatory power to identify the vulnerable plaque, but does provide information about the entire coronary tree and serves as guide for invasive imaging techniques and therapy. Angioscopy offers a direct visualization of the plaque surface and intra- luminal structures like thrombi and tears. However, angioscopy is difficult to perform, invasive and only the proximal part of the vessels can be investigated. IVUS (intravascular ultrasound) provides some insight into the composition of plaques. The detection of vulnerable plaques is mainly based on series of case reports with a lack of prospectivity and follow- up. Palpography, an IVUS derived technique, reveals information, which is not recognizable in IVUS. It can differentiate between deformable and non-deformable tissue, which enables the technique to detect vulnerable plaques with a positive predictive value. The clinical value of palpography is currently under investigation. Thermography assesses the temperature heterogeneity as an indicator of the metabolic state of the plaque. A coincidence of temperature rise and localization of vulnerable plaque was suggested. OCT (optical coherence tomography) can provide images with ultrahigh resolution utililizing the back-reflection of near-infrared light from optical interfaces in tissue. Drawbacks are the low penetration depth into tissue and the absorbance of light by blood. Raman spectroscopy can provide quantification about the molecular composition of the plaque. Long acquisition time, the low penetration depth and light absorbance by blood limit the performance of the technique. Another light emitting technique is NIR (near infrared spectroscopy), which identifies lipid loaded plaques and is tested currently in clinical trials. Non-invasive MRI (magnetic resonance imaging) and multislice spiral computed tomography (MSCT), with their excellent ability to identify lipid-rich tissue, have been utilized to characterize potentially vulnerable plaques foremost in non-moving structures like the carotid arteries. Due to the resolution of the techniques small plaque structure cannot be assessed. The role of non-invasive imaging in vulnerable plaque detection is currently under investigation. Several invasive and non-invasive techniques are currently under development to assess the vulnerable plaque. Most of the techniques show exiting features, but none have proven their value in an extensive in vivo validation and all have a lack of prospective data.

5 August 2021 in European Heart Journal
Verified
Journal Article
Open access
PDF file
JDJeske van Diemen
Jeske van Diemen
PVPetra Verdonk
Petra Verdonk
ACAlaide Chieffo
Alaide Chieffo
EREvelyn Regar
Evelyn Regar
FMFina Mauri
Fina Mauri
YAYolande Appelman
Yolande Appelman
Cardiovascular disease (CVD) is the leading cause of death in men and women worldwide. 1 Although there have been significant advances in reducing CVD-related morbidity and mortality in both sexes, current guideline-directed therapies are based on data that predominantly include male patients. 2 Consequently, in CVD management, female patients might currently be treated equally (the same), however, they are not treated based on equity (i.e. on their health needs).

18 March 2016 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
JSJohannes N. van der Sijde
Johannes N. van der Sijde
AKAntonios Karanasos
Antonios Karanasos
NDNienke S. van Ditzhuijzen
Nienke S. van Ditzhuijzen
TOTakayuki Okamura
Takayuki Okamura
RGRobert-Jan van Geuns
Robert-Jan van Geuns
EREvelyn Regar
Evelyn Regar
Previous studies have reported the safety and feasibility of both time-domain optical coherence tomography (TD-OCT) and Fourier-domain OCT (FD-OCT) in highly selected patients and clinical settings. However, the generalizability of these data is limited, and data in unselected patient populations reflecting a routine cathlab practice are lacking. We compared safety of intracoronary FD-OCT imaging to intravascular ultrasound (IVUS) imaging in a large real-world series of consecutive patients who underwent invasive imaging during coronary catheterization in our centre. This is a prospective, single-centre registry of patients scheduled for coronary angiography or intervention undergoing intracoronary imaging with FD-OCT or IVUS between April 2008 and December 2013. Intra-procedural and major in-hospital adverse events that could be possibly related to invasive imaging were registered routinely by the operator as part of our clinical report and prospectively recorded in our database. These events were retrospectively individually adjudicated by an independent safety committee. Between April 2008 and December 2013, 13 418 diagnostic or interventional coronary catheterization procedures were performed. Of these, 1142 procedures used OCT and 2476 procedures used IVUS. Invasive imaging-related complications were rare, did not differ between the two imaging methods (OCT: n = 7, 0.6%; IVUS: n = 12, 0.5%; P = 0.6), and were self-limiting after retrieval of the imaging catheter or easily treatable in the catheterization laboratory. No major adverse events, prolongation of hospital stay, or permanent patient harm was observed. FD-OCT is safe in an unselected and heterogeneous group of patients with varying clinical settings.